The pill genuinely wins for patients with strong needle aversion, demanding travel schedules, milder weight categories, or those stepping down from injections
The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
Initial Consultation We begin with a comprehensive consultation to review your health history, lifestyle, and body composition goals
In addition to the primary search strategy covering 20002025, manual reference screening of key articles was performed
That same month, a separate NAION lawsuit tied to Wegovy was filed in New Jersey Superior Court
If you have a 12mg vial and add 2mL of bacteriostatic water, you create a 6mg/mL solution